These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3336275)

  • 1. Potency of L-364,718 as an antagonist of the behavioral effects of peripherally administered cholecystokinin.
    Khosla S; Crawley JN
    Life Sci; 1988; 42(2):153-9. PubMed ID: 3336275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of CCK antagonists on CCK-induced suppression of locomotor activity in mice.
    Hirosue Y; Inui A; Miura M; Nakajima M; Okita M; Himori N; Baba S; Kasuga M
    Peptides; 1992; 13(1):155-7. PubMed ID: 1620653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
    Katsuura G; Hsiao S; Itoh S
    Peptides; 1984; 5(3):529-34. PubMed ID: 6089145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.
    Vasar E; Lang A; Harro J; Bourin M; Bradwejn J
    Neuropharmacology; 1994 Jun; 33(6):729-35. PubMed ID: 7936110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.
    O'Neill MF; Dourish CT; Iversen SD
    Eur J Pharmacol; 1991 Feb; 193(2):203-8. PubMed ID: 2050197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
    Crawley JN; Stivers JA; Hommer DW; Skirboll LR; Paul SM
    J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin octapeptide decreases food intake in white-crowned sparrows.
    Richardson RD; Boswell T; Weatherford SC; Wingfield JC; Woods SC
    Am J Physiol; 1993 May; 264(5 Pt 2):R852-6. PubMed ID: 8498593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L364,718 antagonizes the cholecystokinin-induced suppression of locomotor activity.
    Soar J; Hewson G; Leighton GE; Hill RG; Hughes J
    Pharmacol Biochem Behav; 1989 Jul; 33(3):637-40. PubMed ID: 2587606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
    Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hypothalamic cholecystokinin octapeptide in the colonic motor response to a meal in rats.
    Liberge M; Arruebo MP; Bueno L
    Gastroenterology; 1991 Feb; 100(2):441-9. PubMed ID: 1985040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
    Vasar E; Stephenson JD; Meldrum BS
    Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of CART (cocaine- and amphetamine-regulated transcript) peptide and cholecystokinin on food intake regulation in lean mice.
    Maletínská L; Maixnerová J; Matysková R; Haugvicová R; Pirník Z; Kiss A; Zelezná B
    BMC Neurosci; 2008 Oct; 9():101. PubMed ID: 18939974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice.
    Hirosue Y; Inui A; Teranishi A; Miura M; Nakajima M; Okita M; Nakajima Y; Himori N; Baba S; Kasuga M
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R481-6. PubMed ID: 8214137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat].
    Pu SF; Han JS
    Sheng Li Xue Bao; 1993 Oct; 45(5):470-8. PubMed ID: 8146670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.
    Lotti VJ; Pendleton RG; Gould RJ; Hanson HM; Chang RS; Clineschmidt BV
    J Pharmacol Exp Ther; 1987 Apr; 241(1):103-9. PubMed ID: 2437282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a physiological role for CCK in the regulation of food intake in mice.
    Silver AJ; Flood JF; Song AM; Morley JE
    Am J Physiol; 1989 Mar; 256(3 Pt 2):R646-52. PubMed ID: 2923253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of food intake by peripherally administered amylin.
    Morley JE; Flood JF; Horowitz M; Morley PM; Walter MJ
    Am J Physiol; 1994 Jul; 267(1 Pt 2):R178-84. PubMed ID: 8048622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent cholecystokinin antagonist L 364718 stimulates food intake in rats.
    Reidelberger RD; O'Rourke MF
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1512-8. PubMed ID: 2481407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbens.
    Daugé V; Steimes P; Derrien M; Beau N; Roques BP; Féger J
    Pharmacol Biochem Behav; 1989 Sep; 34(1):157-63. PubMed ID: 2626446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
    Millington WR; Mueller GP; Lavigne GJ
    J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.